Aura Organics emerged to fill a significant gap in the skincare market, standing between luxury clinical brands with high prices and mass-market options that compromise on quality and sustainability. It has established a brand focused on trust and substance rather than trends, offering clinical-grade performance with mass-market accessibility. Products are clinically formulated, adhering to rigorous Health Canada and FDA standards, and include trusted dermatologist-grade actives. These are packaged in sustainable materials, contributing to Aura Organics' unique position in Canadian retail. The brand has achieved retailer commitment rather than mere interest, with a confirmed rollout in a major national retailer across over a thousand locations, active placement in many stores, and inclusion in significant drug store databases. Additional interest from a major wholesale club in Canada further underscores its retail validation. The current capital raise is intended to unlock and fund existing demand, emphasizing essential growth aspects such as national retailer activation, inventory scaling tied to confirmed rollouts, and strategic marketing aligned with retail success. Aura Organics is positioned at a pivotal point where costs are set to decrease, margins improve, and brand trust solidifies due to strong physical retail presence. This capital raise reflects an investment opportunity before full national retail execution. The brand seeks to become a defining player in Canadian skincare, a mass-scale clinical alternative, and a potential acquisition target for global entities. Investors are presented with substantial upside due to the brand's existing traction and disciplined growth strategy, backed by a confident valuation for a 25% equity stake at $975,000.